459
Views
27
CrossRef citations to date
0
Altmetric
Review

Commercialization challenges for drug eluting contact lenses

, , , , &
Pages 1133-1149 | Received 13 Feb 2019, Accepted 23 Jun 2020, Published online: 02 Jul 2020

References

  • Glossary of common eye and vision conditions. Am Optom Assoc. https://www.aoa.org/patients-and-public/eye-and-vision-problems/glossary-of-eye-and-vision-conditions
  • Gahl WA, Kuehl EM, Iwata F, et al. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab. 2000;71:100–120.
  • Patel A, Cholkar K, Agrahari V, et al. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2:47–64.
  • Glaucoma facts and stats. Glaucoma Res Found; 2017.
  • Hsu K-H, Carbia BE, Plummer C, et al. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy. Eur J Pharm Biopharm. 2015;94:312–321.
  • Hsu KH, Gause S, Chauhan A. Review of ophthalmic drug delivery by contact lenses. J Drug Deliv Sci Technol. 2014;24:123–135.
  • Man Lam S, Tong L, Duan X, et al. Extensive characterization of human tear fl uid collected using different techniques unravels the presence of novel lipid amphiphiles 1. J Lipid Res. 2014;55:289–298.
  • Zhu H, Chauhan A. A mathematical model for ocular tear and solute balance. Curr Eye Res. 2005;30:841–854.
  • Gause S, Hsu KH, Shafor C, et al. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses. Adv Colloid Interface Sci. 2016;233:139–154.
  • Tripathi BJ, Tripathi RC, Kolli SP. Cytotoxicity of ophthalmic preservatives on human corneal epithelium. Lens Eye Toxic Res. 1992;9:361–375.
  • Watsky MA, Jablonski MM, Edelhauser HF. Comparison of conjunctival and corneal surface areas in rabbit and human. Curr Eye Res. 1988;7:483–486.
  • Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87:1479–1488.
  • Frishman WH, Kowalski M, Nagnur S, et al. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on β-adrenergic blockade. Hear Dis. 2001;3:386–397.
  • Hosoya KI, Lee VHL, Kim KJ. Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation. Eur J Pharm Biopharm. 2005;60:227–240.
  • Saettone MF, Salminen L. Ocular inserts for topical delivery. Adv Drug Deliv Rev. 1995;16:95–106.
  • Leydhecker W. Ocusert. Synopsis of a round-table discussion. Klin Monbl Augenheilkd. 1975;167:917–918.
  • Alvarez-Lorenzo C, Hiratani H, Concheiro A. Contact lenses for drug delivery: achieving sustained release with novel systems. Am J Drug Deliv. 2006;4:131–151.
  • Kim J, Conway A, Chauhan A. Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses. Biomaterials. 2008;29:2259–2269.
  • Peng CC, Burke MT, Chauhan A. Transport of topical anesthetics in vitamin E loaded silicone hydrogel contact lenses. Langmuir. 2011;28:1478–1487.
  • Peng -C-C, Ben-Shlomo A, Mackay EO, et al. Drug delivery by contact lens in spontaneously glaucomatous dogs. Curr Eye Res. 2012;37:204–211.
  • Karlgard CCS, Wong NS, Jones LW, et al. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharm. 2003;257:141–151.
  • Dutta D, Cole N, Kumar N, et al. Broad spectrum antimicrobial activity of melimine covalently bound to contact lenses. Investig Ophthalmol Vis Sci. 2013;54:175–182.
  • Willcox MDP, Hume EBH, Aliwarga Y, et al. A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses. J Appl Microbiol. 2008;105:1817–1825.
  • Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Investig Ophthalmol Vis Sci. 2004;45:2342–2347.
  • Bourlais CL, Acar L, Zia H, et al. Ophthalmic drug delivery systems–recent advances. Prog Retin Eye Res. 1998;17:33–58.
  • McNamara NA, Polse KA, Brand RJ, et al. Tear mixing under a soft contact lens: effects of lens diameter. Am J Ophthalmol. 1999;127:659–665.
  • Creech JL, Chauhan A, Radke CJ. Dispersive mixing in the posterior tear film under a soft contact lens. Ind Eng Chem Res. 2001;40:3015–3026.
  • Xinming L, Yingde C, Lloyd AW, et al. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review. Contact Lens Anterior Eye. 2008;31:57–64.
  • Neefe CW. Contact lenses for olar drug delivery. USA; 1972. p. 1–4.
  • Sedlácek J. Possibility of the application of ophthalmic drugs with the use of gel contact lenses. Cesk Oftalmol. 1965;21:509–512.
  • Hillman JS. Management of acute glaucoma with pilocarpine-soaked hydrophilic lens. Br J Ophthalmol. 1974;58:674–679.
  • Ruben M, Watkins R. Pilocarpine dispensation for the soft hydrophilic contact lens. Br J Ophthalmol. 1975;59:455–458.
  • Schultz CL, Nunez IM, Silor DL, et al. Contact lens containing a leachable absorbed material. Johnson and Johnson Vision Care Inc; 1995.
  • Dixon P, Ghosh T, Mondal K, et al. Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation. Drug Deliv Transl Res. 2018;8:1114–1126.
  • Fathalla D, Soliman GM, Fouad EA. DLatanoprost liposomes for glaucoma treatment development and in vitro/in vivo evaluation of liposomal gels for the sustained ocular delivery of latanoprost. J Clin Exp Ophthalmol. 2015;6:390.
  • Ciolino JB, Hoare TR, Iwata NG, et al. A drug-eluting contact lens. Invest Ophthalmol Vis Sci. 2009;50:3346–3352.
  • Ciolino JB, Hudson SP, Mobbs AN, et al. A prototype antifungal contact lens. Invest Ophthalmol Vis Sci. 2011;52:6286–6291.
  • Paradiso P, Galante R, Santos L, et al. Comparison of two hydrogel formulations for drug release in ophthalmic lenses. J Biomed Mater Res Part B Appl Biomater. 2014;102:1170–1180.
  • Paradiso P, Serro AP, Saramago B, et al. Controlled release of antibiotics from vitamin e–loaded silicone-hydrogel contact lenses. J Pharm Sci. 2016;105:1164–1172.
  • Boone A, Hui A, Jones L. Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses. Eye Contact Lens Sci Clin Pract. 2009;35:260–267.
  • Lim L, Loughnan M, Sullivan L. Microbial keratitis associated with extended wear of silicone hydrogel contact lenses. Br J Ophthalmol. 2002;86:355–357.
  • Fonn D, MacDonald KE, Richter D, et al. The ocular response to extended wear of a high Dk silicone hydrogel contact lens. Clin Exp Optom. 2002;85:176–182.
  • Stark A. U.S. Food and Drug Administration [Internet]. FDA clear. first contact lens with Light. Technol. 2018. Available from: https://www.fda.gov/news-events/press-announcements/fda-clears-first-contact-lens-light-adaptive-technology
  • Rosa Dos Santos JF, Alvarez-Lorenzo C, Silva M, et al. Soft contact lenses functionalized with pendant cyclodextrins for controlled drug delivery. Biomaterials. 2009;30:1348–1355.
  • Jain R, Shastri J. Study of ocular drug delivery system using drug-loaded liposomes. Int J Pharm Investig. 2011;1:35–41.
  • Sekar P, Chauhan A. Effect of vitamin-E integration on delivery of prostaglandin analogs from therapeutic lenses. J Colloid Interface Sci. 2019;539:457–467.
  • Jung HJ, Abou-Jaoude M, Carbia BE, et al. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses. J Control Release. 2013;165:82–89.
  • Braga MEM, Costa VP, Pereira MJT, et al. Effects of operational conditions on the supercritical solvent impregnation of acetazolamide in Balafilcon A commercial contact lenses. Int J Pharm. 2011;420:231–243.
  • Guzman-Aranguez A, Colligris B, Pintor J. Contact lenses: promising devices for ocular drug delivery. J Ocul Pharmacol Ther. 2013;29:189–199.
  • Maulvi FA, Soni TG, Shah DO. A review on therapeutic contact lenses for ocular drug delivery. Drug Deliv. 2016;23:3017–3026.
  • Hu X, Hao L, Wang H, et al. Hydrogel contact lens for extended delivery of ophthalmic drugs. Int J Polym Sci. 2011;2011:814163.
  • Clegg JR, Wechsler ME, Peppas NA. Vision for functionally decorated and molecularly imprinted polymers in regenerative engineering. Regen Eng Transl Med. 2017;3:166–175.
  • Byrne ME, Park K, Peppas NA. Molecular imprinting within hydrogels. Adv Drug Deliv Rev. 2002;1:149–161.
  • Singh B, Chauhan N, Sharma V. Design of molecular imprinted hydrogels for controlled release of cisplatin: evaluation of network density of hydrogels. Ind Eng Chem Res. 2011;50:13742–13751.
  • Ribeiro A, Veiga F, Santos D, et al. Receptor-based biomimetic NVP/DMA contact lenses for loading/eluting carbonic anhydrase inhibitors. J Memb Sci. 2011;383:60–69.
  • Hiratani H, Alvarez-Lorenzo C. The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems. Biomaterials. 2004;25:1105–1113.
  • Ali M, Byrne ME. Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses. Pharm Res. 2009;26:714–726.
  • Tieppo A, White CJ, Paine AC, et al. Sustained in vivo release from imprinted therapeutic contact lenses. 2012.
  • Hiratani H, Mizutani Y, Alvarez-Lorenzo C. Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities. Macromol Biosci. 2005;5:728–733.
  • Alvarez-Lorenzo C, Hiratani H, Gómez-Amoza JL, et al. Soft contact lenses capable of sustained delivery of timolol. J Pharm Sci. 2002;91:2182–2192.
  • Yañez F, Chauhan A, Concheiro A, et al. Timolol-imprinted soft contact lenses: influence of the template: functional monomer ratio and the hydrogel thickness. J Appl Polym Sci. 2011;122:1333–1340.
  • Wulff G. Molecular imprinting in cross‐linked materials with the aid of molecular templates— a way towards artificial antibodies. Angew Chemie Int Ed English. 1995;34:1812–1832.
  • Hiratani H, Fujiwara A, Tamiya Y, et al. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials. 2005;26:1293–1298.
  • Tieppo A, Pate KM, Byrne ME. In vitro controlled release of an anti-inflammatory from daily disposable therapeutic contact lenses under physiological ocular tear flow. Eur J Pharm Biopharm. 2012;81:170–177.
  • Andrade-Vivero P, Fernandez-Gabriel E, Alvarez-Lorenzo C, et al. Improving the loading and release of NSAIDs from pHEMA hydrogels by copolymerization with functionalized monomers. J Pharm Sci. 2007;96:802–813.
  • Hui A, Sheardown H, Jones L, et al. Acetic and acrylic acid molecular imprinted model silicone hydrogel materials for ciprofloxacin-HCl delivery. Materials (Basel). 2012;5:85–107.
  • White CJ, Dipasquale SA, Byrne ME, et al. Controlled release of multiple therapeutics from silicone hydrogel contact lenses. Optom Vis Sci. 2016;93:377–386.
  • Malakooti N, Alexander C, Alvarez-Lorenzo C. Imprinted contact lenses for sustained release of polymyxin b and related antimicrobial peptides. J Pharm Sci. 2015;104:3386–3394.
  • Shoravi S, Olsson GD, Karlsson BCG, et al. On the influence of crosslinker on template complexation in molecularly imprinted polymers: a computational study of prepolymerization mixture events with correlations to template-polymer recognition behavior and NMR spectroscopic studies. Int J Mol Sci. 2010;15:10622–10634.
  • Venkatesh S, Saha J, Pass S, et al. Transport and structural analysis of molecular imprinted hydrogels for controlled drug delivery. Eur J Pharm Biopharm. 2008;69:852–860.
  • White CJ, McBride MK, Pate KM, et al. Extended release of high molecular weight hydroxypropyl methylcellulose from molecularly imprinted, extended wear silicone hydrogel contact lenses. Biomaterials. 2011;32:5698–5705.
  • White C Extended release of macromolecular comfort agents from silicone hydrogel contact lenses. Auburn University; 2011.
  • Alvarez-Lorenzo C, Yañez F, Barreiro-Iglesias R, et al. Imprinted soft contact lenses as norfloxacin delivery systems. J Control Release. 2006;113:236–244.
  • Ohta Y. Possibility of clinical application of vitamin E to cataract prevention. J Clin Biochem Nutr. 2004;35:35–45.
  • Peng -C-C, Chauhan A. Extended cyclosporine delivery by silicone-hydrogel contact lenses. J Control Release. 2011;154:267–274.
  • Peng -C-C, Burke MT, Carbia BE, et al. Extended drug delivery by contact lenses for glaucoma therapy. J Control Release. 2012;162:152–158.
  • Peng CC, Kim J, Chauhan A. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing Vitamin E diffusion barriers. Biomaterials. 2010;31:4032–4047.
  • Kim J, Peng CC, Chauhan A. Extended release of dexamethasone from silicone-hydrogel contact lenses containing vitamin E. J Control Release. 2010;148:110–116.
  • Dixon P, Fentzke RC, Bhattacharya A, et al. In vitro drug release and in vivo safety of vitamin E and cysteamine loaded contact lenses. Int J Pharm. 2018;544:380–391.
  • Hsu K-H, Lazon de la Jara P, Ariyavidana A, et al. Release of betaine and dexpanthenol from vitamin E modified silicone-hydrogel contact lenses. Curr Eye Res. 2015;40:267–273.
  • Hsu KH, Fentzke RC, Chauhan A. Feasibility of corneal drug delivery of cysteamine using vitamin e modified silicone hydrogel contact lenses. Eur J Pharm Biopharm. 2013;85:531–540.
  • Torres-Luna C, Hu N, Tammareddy T, et al. Extended delivery of non-steroidal anti-inflammatory drugs through contact lenses loaded with Vitamin E and cationic surfactants. Contact Lens Anterior Eye. 2019;42:546–552.
  • Ubani-Ukoma U, Gibson D, Schultz G, et al. Evaluating the potential of drug eluting contact lenses for treatment of bacterial keratitis using an ex vivo corneal model. Int J Pharm. 2019;565:499–508.
  • Jung HJ, Chauhan A. Temperature sensitive contact lenses for triggered ophthalmic drug delivery. Biomaterials. 2012;33:2289–2300.
  • Gulsen D, Li CC, Chauhan A. Dispersion of DMPC liposomes in contact lenses for ophthalmic drug delivery. Curr Eye Res. 2005;30:1071–1080.
  • Singh K, Mezei M. Liposomal ophthalmic drug delivery system I. Triamcinolone acetonide. Int J Pharm. 1983;16:339–344.
  • Sercombe L, Veerati T, Moheimani F, et al. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286.
  • Monteiro N, Martins A, Reis RL, et al. Liposomes in tissue engineering and regenerative medicine. J R Soc Interface. 2014;11:20140459.
  • Meisner D, Mezei M. Liposome ocular delivery systems. Adv Drug Deliv Rev. 1995;16:75–93.
  • Agarwal R, Iezhitsa I, Agarwal P, et al. Liposomes in topical ophthalmic drug delivery: an update. Drug Deliv. 2014;23:1–17.
  • Ulrich AS. Biophysical aspects of using liposomes as delivery vehicles. Biosci Rep. 2002;22:129–150.
  • Danion A, Brochu H, Martin Y, et al. Fabrication and characterization of contact lenses bearing surface-immobilized layers of intact liposomes. J Biomed Mater Res A. 2007;82A:41–51.
  • Maulvi FA, Patil RJ, Desai AR, et al. Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: in vitro and in vivo evaluation. Acta Biomater. 2019;86:350–362.
  • Maulvi FA, Choksi HH, Desai AR, et al. pH triggered controlled drug delivery from contact lenses: addressing the challenges of drug leaching during sterilization and storage. Colloids Surf B Biointerfaces. 2017;157:72–82.
  • Maulvi FA, Mangukiya MA, Patel PA, et al. Extended release of ketotifen from silica shell nanoparticle-laden hydrogel contact lenses: in vitro and in vivo evaluation. J Mater Sci Mater Med. 2016;27:113.
  • Maulvi FA, Soni TG, Shah DO. Extended release of timolol from ethyl cellulose microparticles laden hydrogel contact lenses. Open Pharm Sci J. 2015;2:1–12.
  • Maulvi FA, Parmar RJ, Shukla MR, et al. Plackett-Burman design for screening of critical variables and their effects on the optical transparency and swelling of gatifloxacin-pluronic-loaded contact lens. Int J Pharm. 2019;566:513–519.
  • Maulvi FA, Parmar RJ, Desai AR, et al. Tailored gatifloxacin Pluronic® F-68-loaded contact lens: addressing the issue of transmittance and swelling. Int J Pharm. 2020;581:119279.
  • Toh M-R, Chiu GNC. Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing. Asian J Pharm Sci. 2013;8:88–95.
  • Nasr FH, Khoee S, Dehghan MM, et al. Preparation and evaluation of contact lenses embedded with polycaprolactone-based nanoparticles for ocular drug delivery. Biomacromolecules. 2016;17:485–495.
  • Choi JS, Seo K, Yoo JW. Recent advances in PLGA particulate systems for drug delivery. J Pharm Investig. 2012;42:155–163.
  • Ciolino JB, Ross AE, Tulsan R, et al. Latanoprost-eluting contact lenses in glaucomatous monkeys. Ophthalmology. 2016;123:2085–2092.
  • Maulvi FA, Shaikh AA, Lakdawala DH, et al. Design and optimization of a novel implantation technology in contact lenses for the treatment of dry eye syndrome: in vitro and in vivo evaluation. Acta Biomater. 2017;53:211–221.
  • Desai AR, Maulvi FA, Pandya MM, et al. Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma:: in vitro and in vivo evaluation. Biomater Sci. 2018;1580–1591. DOI:10.1039/C8BM00212F
  • Maulvi FA, Singhania SS, Desai AR, et al. Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis. Int J Pharm. 2018;548:139–150.
  • Maulvi FA, Lakdawala DH, Shaikh AA, et al. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery. J Control Release. 2016;226:47–56.
  • Ross AE, Bengani LC, Tulsan R, et al. Topical sustained drug delivery to the retina with a drug-eluting contact lens. Biomaterials. 2019;217:119285.
  • Guzman G, Es-haghi SS, Nugay T, et al. Zero-order antibiotic release from multilayer contact lenses: nonuniform drug and diffusivity distributions produce constant-rate drug delivery. Adv Healthc Mater. 2017;6:1600775.
  • Hu X, Tan H, Li D, et al. Surface functionalisation of contact lenses by CS/HA multilayer film to improve its properties and deliver drugs. Mater Technol Adv Perform Mater. 2014;29:8–13.
  • Lin CH, Cho HL, Yeh YH, et al. Improvement of the surface wettability of silicone hydrogel contact lenses via layer-by-layer self-assembly technique. Colloids Surf B Biointerfaces. 2015;136:735–743.
  • Yu Y, Macoon R, Chauhan A. Improving wettability and lubricity of commercial contact lenses by polymerizing a thin film of dimethylacryamide. Colloids Surf A Physicochem Eng Aspects. 2019;583:123974.
  • Desai AR, Maulvi FA, Desai DM, et al. Multiple drug delivery from the drug-implants-laden silicone contact lens: addressing the issue of burst drug release. Mater Sci Eng C. 2020;112:110885.
  • Fu K, Pack DW, Klibanov AM, et al. Visual evidence of acidic environment within degrading poly(lactic-co- glycolic acid) (PLGA) microspheres. Pharm Res. 2000;17:100–106.
  • Markoulli M, Papas E, Cole N, et al. Corneal erosions in contact lens wear. Contact Lens Anterior Eye. 2012;35:2–8.
  • Mandell RB. Contact lens practice. 4th ed. Springfield (IL): Charles C Thomas Pub Ltd; 1988.
  • Markoulli M, Kolanu S. Contact lens wear and dry eyes: challenges and solutions. Clin Optom. 2017;9:41–48.
  • Urgacz A, Mrukwa E, Gawlik R. Adverse events in allergy sufferers wearing contact lenses. Postep Dermatologii I Alergol. 2015;32:204–209.
  • Sekston A. Johnson & Johnson Vision [Internet]. Johnson Johnson Vision’s Investig. Antihistamine-releasing contact lens demonstr. Posit. Phase 3 Results. 2019. Available from: https://www.jjvision.com/press-release/johnson-johnson-visions-investigational-antihistamine-releasing-contact-lens
  • Taniguchi EV, Kalout P, Pasquale LR, et al. Clinicians’ perspectives on the use of drug-eluting contact lenses for the treatment of glaucoma. Ther Deliv. 2014;5:1077–1083.
  • Schultz CL, Poling TR, Mint JO. A medical device/drug delivery system for treatment of glaucoma. Clin Exp Optom. 2009;92:343–348.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.